{
    "nct_id": "NCT03699995",
    "official_title": "Imaging Modalities for Melanoma Screening and Diagnosis",
    "inclusion_criteria": "* Persons who participate in the free skin cancer screening at the PDX Skincare Festival at Oregon Health & Science University (OHSU) in 2021/2022 (date pending) and are informed by a provider that they have a pigmented lesion for which a biopsy is recommended are potentially eligible to participate in this study.\n* Persons who participate in the free skin cancer screening at the War on Skin Cancer event at OHSU in 2021/2022 (date pending) or other dates and locations and are informed by a provider that they have a clinically benign or atypical nevi are eligible to participate in the imaging portion of this study. No biopsy will be offered to these participants.\n* Persons age 18-80 are eligible for the study\n* Persons of any sex can be enrolled.\n* Persons of any race are eligible but we anticipate that most participants will be Non-Hispanic whites due to the prevalence of melanoma and other skin cancers in this group.\n* Only persons who can provide signed statement of informed consent will be enrolled.\n* Persons who are identified in OHSU Dermatology clinics or through OHSU e-visit and e-consult platforms as having a skin lesion in need of a biopsy for skin cancer\n* Persons identified via the Melanoma Community Registry (MCR) (IRB approved: 00010561)\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* Allergy to the anesthetic (lidocaine).",
    "miscellaneous_criteria": ""
}